Mukka Proteins Limited (NSE:MUKKA)
24.70
-0.46 (-1.83%)
Nov 20, 2026, 11:20 AM IST
Mukka Proteins Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 19, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 7,410 | 5,547 | 9,798 | 10,950 | - | - | |
Market Cap Growth | -2.68% | -43.39% | -10.52% | - | - | - |
Enterprise Value | 15,100 | 11,294 | 13,777 | 14,093 | - | - |
Last Close Price | 25.16 | 18.49 | 32.66 | 36.50 | - | - |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 19, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 9.39 | 10.66 | 21.09 | 15.63 | - | - |
PS Ratio | 0.36 | 0.38 | 0.97 | 0.79 | - | - |
PB Ratio | 1.38 | 1.05 | 2.15 | 2.68 | - | - |
P/TBV Ratio | 1.42 | 1.14 | 2.26 | 2.77 | - | - |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 19, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
EV/Sales Ratio | 0.74 | 0.78 | 1.37 | 1.02 | - | - |
EV/EBITDA Ratio | 8.74 | 9.90 | 14.51 | 13.02 | - | - |
EV/EBIT Ratio | 9.85 | 11.24 | 16.55 | 14.69 | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 19, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Debt / Equity Ratio | 1.61 | 1.47 | 0.99 | 0.90 | 1.68 | 1.70 |
Debt / EBITDA Ratio | 4.95 | 6.66 | 4.68 | 3.37 | 2.98 | 3.50 |
Net Debt / Equity Ratio | 1.47 | 1.45 | 0.99 | 0.66 | 1.51 | 1.59 |
Net Debt / EBITDA Ratio | 4.61 | 6.72 | 4.74 | 2.50 | 2.68 | 3.30 |
Net Debt / FCF Ratio | -5.88 | -3.07 | -3.31 | -1.61 | -3.59 | -96.24 |
Asset Turnover | 1.31 | 1.08 | 1.00 | 1.82 | 2.44 | 2.07 |
Inventory Turnover | 1.96 | 1.65 | 1.57 | 3.48 | 4.78 | 4.04 |
Quick Ratio | 0.32 | 0.21 | 0.36 | 0.56 | 0.38 | 0.27 |
Current Ratio | 1.27 | 1.23 | 1.52 | 1.57 | 1.15 | 1.04 |
Return on Equity (ROE) | 17.16% | 11.59% | 11.12% | 26.34% | 36.71% | 30.00% |
Return on Assets (ROA) | 6.15% | 4.66% | 5.16% | 7.91% | 9.83% | 6.95% |
Return on Invested Capital (ROIC) | 8.58% | 6.93% | 8.38% | 15.22% | 16.66% | 12.10% |
Return on Capital Employed (ROCE) | 23.00% | 17.60% | 17.90% | 22.80% | 44.20% | 35.80% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 19, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Earnings Yield | 10.65% | 9.38% | 4.74% | 6.40% | - | - |
FCF Yield | -17.88% | -44.98% | -13.88% | -15.35% | - | - |
Buyback Yield / Dilution | -1.45% | - | -32.93% | -2.58% | - | - |